ImmunityBio, Inc. IBRX Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s finance lease liabilities (total)?
- ImmunityBio, Inc. (IBRX) reported finance lease liabilities (total) of $266K in Q1 2026.
- What is the long-term trend for ImmunityBio, Inc.'s finance lease liabilities (total)?
- Over 2 years (2022 to 2025), ImmunityBio, Inc.'s finance lease liabilities (total) has grown at a 40.7% compound annual growth rate (CAGR), from $141K to $279K.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.